Alliance BioEnergy Plus, Inc. CEO Gives Update to Ongoing Development and Commercialization Efforts of the Patented CTS process

WEST PALM BEACH, Fla., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Alliance BioEnergy Plus, Inc. (OTCQB:ALLM) (the “Company”) CEO Daniel de Liege is pleased to announce the continued success of the development and commercialization efforts of the patented CTS process.

Over the last six months, significant milestones have been met and surpassed in the ongoing efforts to commercialize the patented CTS process. An additional patent has been issued, bringing the CTS patent family to four issued and fourteen filed and pending; a variety of feedstocks, including Corn Stover, Sugar Cane Bagasse, Distillers Grains and Specialty Grasses have been optimized; a prototype commercial scale CTS reactor has been designed, built and tested with great success, which has greatly reduced energy consumption and lowered the overall operating expense of the process; DoE grants and FOA applications that have been filed have been met with enthusiasm and passed initial rounds of scrutiny and comments; and advanced negotiations are underway with various commercial and public organizations for the licensing and application of the CTS process.

As the efforts continue it is imperative that shareholders and company supporters understand that the Company is in just its 3rd year of development of this brand new technology and that it has only been 18 months since the completion of the Pilot scale process. The normal timeline for developing and commercializing a new technology in a new market is anywhere from eight to nineteen years with the average being fourteen years (McKinsey&Company: Chemical innovation: An investment for the ages). The CTS process is poised to be commercialized and running in a new market in less than three years. A testament not only to the scientific and management team of ALLM but to the process itself.

Company CEO, Daniel de Liege said “The Company will continue to work with its engineering partners on the optimization and commercialization of this highly coveted Cellulosic conversion process. We are working with existing petroleum and biofuels Companies on various uses for the CTS technology as well as working toward Company owned facilities. We have been able to bring this very important, disruptive technology to market for a fraction of the cost of any competing technology and we did it without taking tax payer dollars, Wall Street funds with strings attached or foreign investment”. He went on to say, “We are on the 2-yard line and if all goes well we expect to be in revenue this year and then see significant revenue and profits in 2017.”

About ALLM:

Alliance BioEnergy +, Inc. (“ALLM”) is a publicly traded company focusing on the commercialization and licensing of a patented cellulose conversion technology that it controls through a master license agreement with the University of Central Florida. ALLM’s subsidiary, AMG Energy Group, LLC (“AMG”), owns 50% of Carbolosic, LLC, in a joint venture with Thor Renewable Energy Singapore. Carbolosic holds the exclusive, worldwide license to four (4) issued patents and fourteen (14) filed and pending patents revolving around the core CTS (cellulose to sugar) technology. ALLM also holds the exclusive CTS rights to North America (Canada, US, and Mexico) and Africa.

The CTS process is the only known patented, dry mechanical process that can convert virtually any cellulose material into sugars and other products in a matter of minutes with no liquid acids, no applied heat, pressure or hazardous materials of any kind. The CTS process when used in the production of Ethanol is clean, less expensive to build and operate than traditional ethanol plants or other cellulose ethanol technologies and is completely environmentally friendly.

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Alliance BioEnergy Plus, Inc. actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Alliance Media Group Holdings, Inc’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Alliance BioEnergy Plus, Inc herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Alliance BioEnergy Plus, Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

Contact: Public Relations and Media Contact: LCG Headquarter Office 702.333.4886

Source:Alliance BioEnergy Plus, Inc.